» Articles » PMID: 20507948

Clinical Characteristics and Outcomes of Sepsis-related Vs Non-sepsis-related ARDS

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2010 May 29
PMID 20507948
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

Background: ARDS may occur after either septic or nonseptic injuries. Sepsis is the major cause of ARDS, but little is known about the differences between sepsis-related and non-sepsis-related ARDS.

Methods: A total of 2,786 patients with ARDS-predisposing conditions were enrolled consecutively into a prospective cohort, of which 736 patients developed ARDS. We defined sepsis-related ARDS as ARDS developing in patients with sepsis and non-sepsis-related ARDS as ARDS developing after nonseptic injuries, such as trauma, aspiration, and multiple transfusions. Patients with both septic and nonseptic risks were excluded from analysis.

Results: Compared with patients with non-sepsis-related ARDS (n = 62), patients with sepsis-related ARDS (n = 524) were more likely to be women and to have diabetes, less likely to have preceding surgery, and had longer pre-ICU hospital stays and higher APACHE III (Acute Physiology and Chronic Health Evaluation III) scores (median, 78 vs 65, P < .0001). There were no differences in lung injury score, blood pH, Pao(2)/Fio(2) ratio, and Paco(2) on ARDS diagnosis. However, patients with sepsis-related ARDS had significantly lower Pao(2)/Fio(2) ratios than patients with non-sepsis-related ARDS patients on ARDS day 3 (P = .018), day 7 (P = .004), and day 14 (P = .004) (repeated-measures analysis, P = .011). Compared with patients with non-sepsis-related ARDS, those with sepsis-related had a higher 60-day mortality (38.2% vs 22.6%; P = .016), a lower successful extubation rate (53.6% vs 72.6%; P = .005), and fewer ICU-free days (P = .0001) and ventilator-free days (P = .003). In multivariate analysis, age, APACHE III score, liver cirrhosis, metastatic cancer, admission serum bilirubin and glucose levels, and treatment with activated protein C were independently associated with 60-day ARDS mortality. After adjustment, sepsis-related ARDS was no longer associated with higher 60-day mortality (hazard ratio, 1.26; 95% CI, 0.71-2.22).

Conclusion: Sepsis-related ARDS has a higher overall disease severity, poorer recovery from lung injury, lower successful extubation rate, and higher mortality than non-sepsis-related ARDS. Worse clinical outcomes in sepsis-related ARDS appear to be driven by disease severity and comorbidities.

Citing Articles

Total bilirubin as a marker for hemolysis and outcome in patients with severe ARDS treated with veno-venous ECMO.

Bunger V, Menk M, Hunsicker O, Krannich A, Balzer F, Spies C BMC Anesthesiol. 2025; 25(1):121.

PMID: 40082753 PMC: 11905513. DOI: 10.1186/s12871-025-02988-1.


Circulating extracellular vesicles as potential biomarkers and mediators of acute respiratory distress syndrome in sepsis.

do Nascimento M, Ferreira L, Vieira Junior J, Deheinzelin D, Aparecida Santos Nussbaum A, Toshihiro Sakamoto L Sci Rep. 2025; 15(1):5512.

PMID: 39953195 PMC: 11829037. DOI: 10.1038/s41598-025-89783-7.


Role of Cellular Senescence Genes and Immune Infiltration in Sepsis and Sepsis-Induced ARDS Based on Bioinformatics Analysis.

Wu X, Guo Y J Inflamm Res. 2024; 17:9119-9133.

PMID: 39588141 PMC: 11586271. DOI: 10.2147/JIR.S488463.


Subphenotypic features of patients with sepsis and ARDS: a multicenter cohort study.

Li N, Fang D, Ge F, Zhang L, Liu Y, Jin H Front Med (Lausanne). 2024; 11:1476512.

PMID: 39554506 PMC: 11563817. DOI: 10.3389/fmed.2024.1476512.


Precision Medicine in Acute Respiratory Distress Syndrome: Progress, Challenges, and the Road ahead.

Leonard J, Sinha P Clin Chest Med. 2024; 45(4):835-848.

PMID: 39443001 PMC: 11507056. DOI: 10.1016/j.ccm.2024.08.005.


References
1.
Cooke C, Kahn J, Caldwell E, Okamoto V, Heckbert S, Hudson L . Predictors of hospital mortality in a population-based cohort of patients with acute lung injury. Crit Care Med. 2008; 36(5):1412-20. DOI: 10.1097/CCM.0b013e318170a375. View

2.
Whitcomb B, Pradhan E, Pittas A, Roghmann M, Perencevich E . Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Crit Care Med. 2005; 33(12):2772-7. DOI: 10.1097/01.ccm.0000189741.44071.25. View

3.
Matthay M, Zimmerman G, Esmon C, Bhattacharya J, Coller B, Doerschuk C . Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med. 2003; 167(7):1027-35. DOI: 10.1164/rccm.200208-966WS. View

4.
Eisner M, Thompson T, Hudson L, Luce J, Hayden D, Schoenfeld D . Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001; 164(2):231-6. DOI: 10.1164/ajrccm.164.2.2011093. View

5.
Alba-Loureiro T, Munhoz C, Martins J, Cerchiaro G, Scavone C, Curi R . Neutrophil function and metabolism in individuals with diabetes mellitus. Braz J Med Biol Res. 2007; 40(8):1037-44. DOI: 10.1590/s0100-879x2006005000143. View